Skip to content

Optimizing Rehabilitation in People with Multiple Sclerosis

Optimizing Rehabilitation in People with Multiple Sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240709062370N1
Enrollment
30
Registered
2024-07-15
Start date
2024-08-05
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis (MS). Multiple sclerosis

Interventions

Intervention 1: The optimal group (intervention): this group will participate in exactly the same pre-tests and post-tests as the control group. The equipment used, the duration of training sessions,

Sponsors

The University of Isfahan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: clinical diagnosis of MS years of age 30-50 patients with a range of disabilities, with scores on the Expanded Disability Status Scale (EDSS) from 2.00 to 4.00 ability to walk without aid (e.g., cane),

Exclusion criteria

Exclusion criteria: cognitive impairments other neurologic disorders severe contracture in the lower limbs

Design outcomes

Primary

MeasureTime frame
Static and dynamic balance. Timepoint: Pre test, mid test, post test. Method of measurement: Timed Up and Go test.

Secondary

MeasureTime frame
Static and dynamic balance. Timepoint: Pre test, Post test. Method of measurement: Timed Up and Go test (TUG).;Depression symptoms. Timepoint: Pre test, Post test. Method of measurement: Beck Depression Inventory.;Walking speed. Timepoint: Pre test, Post test. Method of measurement: 25 foot walking.;Fatigue. Timepoint: Post test. Method of measurement: The Fatigue Scale for Motor and Cognitive Functions, Multiple Sclerosis.;Quality of life. Timepoint: Post test. Method of measurement: Multiple Sclerosis Impact Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Salehi

The University of Isfahan

Dr.Salehi@gmail.com+98 31 3793 2577

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026